Bausch and Lomb

3 Stories

Dow Surges After Asian Bleeding, Roller-Coaster Day

(Newser) - Wall Street is dizzy after mixed signals threw traders into buy mode despite an abundance of bearish indicators today, making for one of the most volatile days in weeks. The Dow finished up 150.38 points at 13362.37, even after Asian markets plummeted across the board last night, a... More »

Eye-Care Recall Reverberates on Wall Street

Product problem seen influencing bids for Bausch & Lomb

(Newser) - In the wake of reports linking its Complete MoisturePlus contact lens solution to a rare eye infection that can lead to blindness, Advanced Medical Optics has recalled the product. Competitor Bausch & Lomb's stock price dropped on the news, since the recall may put AMO's plans to enter the bidding... More »

Private Equity Firm Eyes Bausch & Lomb

Troubled contact lens giant fields $4.5B buyout offer

(Newser) - Bausch & Lomb is seeing the private equity light at the end of the tunnel. After a year of costly recalls, accounting snafus, and lawsuits that have shaken the contact lens giant, B&L is entertaining a $4.5 billion offer—including $830 million in debt—from Warburg Pincus. The... More »

3 Stories